Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute

B. Balbi, M. Vitacca, P. Ceriana, M. Carone, G. Balzano, A. Zanini, C. Fracchia, P. Santus, A. Capelli, G. Piaggi, G. Callegari, I. Ferrarotti, M. Luisetti, A. Spanevello (Veruno, Lumezzane, Pavia, Cassano, Telese, Tradate, Montescano, Milano, Italy)

Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Session: The best posters in pulmonary rehabilitation
Session type: Poster Discussion
Number: 3567
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Balbi, M. Vitacca, P. Ceriana, M. Carone, G. Balzano, A. Zanini, C. Fracchia, P. Santus, A. Capelli, G. Piaggi, G. Callegari, I. Ferrarotti, M. Luisetti, A. Spanevello (Veruno, Lumezzane, Pavia, Cassano, Telese, Tradate, Montescano, Milano, Italy). Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute. Eur Respir J 2013; 42: Suppl. 57, 3567

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014


Health locus of control in pulmonary rehabilitation (PR) of severe COPD patients
Source: International Congress 2016 – Latest insights into pulmonary rehabilitation
Year: 2016


Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


The progress of BODE(survival) index by 165 patients with severe and very severe COPD (GOLD III-IV) after 3 weeks of inpatient pulmonary rehabilitation (PR)
Source: International Congress 2014 – Best posters in physical activity, exercise testing and muscles
Year: 2014


Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015

The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015


Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015


Screening for alpha1-antitrypsin deficiency at a university hospital
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

Psychological co-morbidities in patients with COPD: Which changes can be observed during inpatient pulmonary rehabilitation (PR)?
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014


Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Investigation of sarcopenia in Japanese COPD patients
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015

Impact of chronic obstructive pulmonary disease (COPD) and patients' absence from work in Greece - the GOLDEN II study
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014

Pulmonary rehabilitation (PR) in adults with COPD and Heart Failure (HF); data from the UK 2015 National COPD:PR Audit
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


Mortality predictive factors in COPD patients after a pulmonary rehabilitation programme - a 3 years study
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1
Year: 2014


Perceptions about exercise and pulmonary rehabilitation in two Arabic Gulf countries (Iraq and State of Qatar); a qualitative study in patients with chronic obstructive pulmonary disease (COPD) and their health care providers
Source: International Congress 2014 – Best posters in physical activity, exercise testing and muscles
Year: 2014


The influence of malnutrition on pulmonary rehabilitation in patients with COPD
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014


The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013